4//SEC Filing
MURDOCK TERRY L 4
Accession 0001562180-24-005607
CIK 0001560241other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 5:32 PM ET
Size
9.1 KB
Accession
0001562180-24-005607
Insider Transaction Report
Form 4
MURDOCK TERRY L
SVP of Development Operations
Transactions
- Award
Common Stock
2024-07-01+35,000→ 130,487 total
Footnotes (3)
- [F1]Represents a restricted stock unit ("RSU") award that vests 50% on July 1, 2025 and 50% on July 1, 2026, subject to the Reporting Person's continued service through each applicable vesting date.
- [F2]Each RSU represents a contingent right to receive one share of Issuer common stock.
- [F3]Represents (i) 18,512 shares of common stock; (ii) 2,750 RSUs from award granted on January 4, 2021; (iii) 6,000 RSUs from award granted on January 3, 2022; (iv) 13,425 RSUs from award granted on January 3, 2023; (v) 17,500 RSUs from award granted on May 10, 2023; and (vi) 37,300 RSUs from award granted on January 3, 2024; and (vii) 35,000 RSUs from award granted on July 1, 2024.
Issuer
G1 Therapeutics, Inc.
CIK 0001560241
Entity typeother
Related Parties
1- filerCIK 0001274071
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 5:32 PM ET
- Size
- 9.1 KB